Eli Lilly's oral GLP-1 receptor agonist Orforglipron showed significant weight loss, A1C reduction, and cardiometabolic ...

Michael Grosberg, vice president of product management, spoke with Pharmaceutical Executive about direct-to-consumer sales ...

Putnam’s CEO discusses advancements in oncology and how companies are working to ensure patients have access to these new ...

The collaboration provides BioArctic with an upfront payment of $30 million and potential milestone and royalty payments as ...

Genentech broke ground on a $700 million manufacturing facility in Holly Springs, North Carolina its first on the U.S. East ...

The acquisition adds Furoscix, an FDA-approved furosemide infusion therapy for chronic heart failure and kidney disease, ...